Form 8-K - Current report:
SEC Accession No. 0001193125-22-242398
Filing Date
2022-09-12
Accepted
2022-09-12 07:01:01
Documents
14
Period of Report
2022-09-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d395778d8k.htm   iXBRL 8-K 28956
2 EX-99.1 d395778dex991.htm EX-99.1 9465
6 GRAPHIC g395778g0912072301581.jpg GRAPHIC 3881
  Complete submission text file 0001193125-22-242398.txt   170679

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA txmd-20220906.xsd EX-101.SCH 2879
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20220906_lab.xml EX-101.LAB 17996
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20220906_pre.xml EX-101.PRE 11277
8 EXTRACTED XBRL INSTANCE DOCUMENT d395778d8k_htm.xml XML 3347
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 221237355
SIC: 2834 Pharmaceutical Preparations